Jupiter Investment Management’s AbbVie ABBV Stock Holding History

Jupiter Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$18.7M	Sell	190,912 -120,874	-39%	-$10.6M	0.3%	95
2020 Q1	$23.8M	Sell	311,786 -827,418	-73%	-$70.5M	0.46%	67
2019 Q4	$101M	Buy	1,139,204 +1,008,736	+773%	+$83.7M	1.4%	10
2019 Q3	$9.88M	Sell	130,468 -596,172	-82%	-$40.9M	0.13%	174
2019 Q2	$52.8M	Buy	726,640 +660,652	+1,001%	+$51.9M	0.54%	68
2019 Q1	$5.32M	Buy	65,988 +28,142	+74%	+$2.3M	0.05%	179
2018 Q4	$3.49M	Sell	37,846 -35,640	-48%	-$3.13M	0.03%	187
2018 Q3	$6.95M	Sell	73,486 -13,754	-16%	-$1.3M	0.05%	170
2018 Q2	$8.08M	Sell	87,240 -12,974	-13%	-$1.27M	0.06%	177
2018 Q1	$9.48M	Buy	+100,214	New	+$11M	0.08%	158
2017 Q4	–	Sell	-24,868	Closed	-$2.21M	–	361
2017 Q3	$2.21M	Buy	24,868 +6,700	+37%	+$510K	0.02%	192
2017 Q2	$1.32M	Hold	18,168	–	–	0.02%	238
2017 Q1	$1.18M	Buy	18,168 +256	+1%	+$16.1K	0.02%	228
2016 Q4	$1.12M	Sell	17,912 -671,052	-97%	-$41M	0.02%	210
2016 Q3	$43.5M	Buy	688,964 +685,819	+21,807%	+$44.4M	0.75%	50
2016 Q2	$194K	Sell	3,145 -153,143	-98%	-$9.33M	﹤0.01%	370
2016 Q1	$8.93M	Buy	156,288 +139,915	+855%	+$7.8M	0.18%	136
2015 Q4	$969K	Buy	16,373 +4,255	+35%	+$245K	0.03%	186
2015 Q3	$659K	Sell	12,118 -20,094	-62%	-$1.31M	0.02%	222
2015 Q2	$2.16M	Sell	32,212 -82,927	-72%	-$5.41M	0.06%	134
2015 Q1	$6.74M	Buy	115,139 +86,749	+306%	+$5.24M	0.21%	96
2014 Q4	$1.86M	Buy	+28,390	New	+$1.79M	0.07%	211

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Jupiter Investment Management's ABBV Position: Q2 2020 in Review

Jupiter Investment Management reduced its AbbVie (ABBV) stake by 39% in Q2 2020, selling an estimated $10.6M and leaving 190,912 shares worth $18.7M. The position accounts for 0.3% of the portfolio, ranked #95.

Jupiter Investment Management first reported a position in ABBV in Q4 2014 and has held it in 22 quarters since. The position peaked at $101M in Q4 2019. 2,411 funds tracked by Wall St. Rank hold ABBV as of Q2 2020.

Jupiter Investment Management held 190,912 shares of AbbVie worth $18.7M as of Q2 2020.
Jupiter Investment Management sold 120,874 AbbVie shares in Q2 2020, an estimated $10.6M.
AbbVie made up 0.3% of Jupiter Investment Management's portfolio in Q2 2020, its #95 holding.
Jupiter Investment Management first reported a position in AbbVie in Q4 2014 and has held it in 22 quarters since.
Jupiter Investment Management's AbbVie position peaked at $101M in Q4 2019.
2,411 funds tracked by Wall St. Rank held AbbVie as of Q2 2020.

Based on Jupiter Investment Management's 13F filing for Q2 2020, filed 13 Jul 2020.